Merck
MRK
#62
Rank
ยฃ185.33 B
Marketcap
ยฃ74.20
Share price
-0.79%
Change (1 day)
-6.40%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): ยฃ5.76

According to Merck's latest financial reports the company's current EPS (TTM) is ยฃ5.70. In 2024 the company made an earnings per share (EPS) of ยฃ5.07 an increase over its 2023 EPS that were of ยฃ0.11.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ5.7613.63%
2024ยฃ5.074308.46%
2023ยฃ0.11-97.32%
2022ยฃ4.3010.92%
2021ยฃ3.8784.68%
2020ยฃ2.10-27.2%
2019ยฃ2.8863.44%
2018ยฃ1.76151.11%
2017ยฃ0.70-54.58%
2016ยฃ1.5530.21%
2015ยฃ1.19-61.99%
2014ยฃ3.12180.51%
2013ยฃ1.11-31.82%
2012ยฃ1.636.62%
2011ยฃ1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ1.29-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.83 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ15.39 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ2.23-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.78-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
ยฃ2.70-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
ยฃ5.52-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
ยฃ6.04 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ9.77 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA